Avidity Biosciences
158 hedge funds and large institutions have $2.28B invested in Avidity Biosciences in 2024 Q1 according to their latest regulatory filings, with 36 funds opening new positions, 51 increasing their positions, 52 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
158
Holders Change
+14
Holders Change %
+9.72%
% of All Funds
2.29%
Holding in Top 10
7
Holding in Top 10 Change
+5
Holding in Top 10 Change %
+250%
% of All Funds
0.1%
New
36
Increased
51
Reduced
52
Closed
21
Calls
$3.06M
Puts
$1.74M
Net Calls
+$1.32M
Net Calls Change
+$909K
Top Buyers
| 1 |
1
Fidelity Investments
Boston,
Massachusetts
|
$363M |
| 2 |
ACA
2
Avoro Capital Advisors
New York
|
$149M |
| 3 |
RI
3
RTW Investments
New York
|
$203M |
| 4 |
4
Janus Henderson Group
London,
United Kingdom
|
$31.7M |
| 5 |
O
5
OrbiMed
New York
|
$25.4M |
Top Sellers
| 1 |
1
Morgan Stanley
New York
|
$39.2M |
| 2 |
2
Balyasny Asset Management
Chicago,
Illinois
|
$1.3M |
| 3 |
3
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
$3.44M |
| 4 |
4
Dimensional Fund Advisors
Austin,
Texas
|
$25.8M |
| 5 |
5
Two Sigma Investments
New York
|
$6.31M |
